Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2021-03-25 Earnings Release
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Half-year Report
Earnings Release Classification · 1% confidence The document is explicitly titled 'Half Year Report' and contains detailed 'Financial Highlights' and 'Operating Highlights' for the six months ended 31 December 2020. This structure, covering a period shorter than a full year with comprehensive financial data, aligns perfectly with the definition of an Interim/Quarterly Report. The RNS Number (4065T) indicates it was released via a regulatory news service, but the content itself is the full report, not just an announcement of its publication. Therefore, the classification is Interim / Quarterly Report (IR). H1 2020
2021-03-25 English
Distribution agreement
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 5536R' and is clearly formatted as a regulatory news service announcement from the London Stock Exchange (LSE), indicated by the footer mentioning 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' The content announces a specific business event: 'Genedrive enters distribution agreement with Mountain Horse Solutions'. This is a material, non-financial announcement that does not fit the specific categories like 10-K, ER, or IR. Since it is a general regulatory announcement distributed via RNS and doesn't fit a more specific category (like DIRS, DIV, or M&A), the most appropriate classification is the general Regulatory Filings category (RNS). The document length is moderate, but the content is purely an announcement of a contract, not the full report itself.
2021-03-09 English
Antibiotic Induced Hearing Loss update
Legal Proceedings Report Classification · 1% confidence The document is identified by the header 'RNS Number : 9259Q' and contains a date (03 March 2021) and company information, typical of a regulatory announcement disseminated via the Regulatory News Service (RNS). The content is an 'Antibiotic Induced Hearing Loss update' providing clinical trial results, new guidance impact, and commercial outlook. It is not a full Annual Report (10-K), a formal Audit Report (AR), or a specific financial statement. Since it is a general update disseminated through the RNS system, and it doesn't fit the specific categories like ER, IR, or DIV, the most appropriate general classification for a non-regulatory news service announcement distributed via RNS is 'Regulatory Filings' (RNS), as per the provided definitions and the explicit mention of 'Reach is a non-regulatory news service' at the end, which often defaults to RNS if no other specific category applies, or RNS if it is a general regulatory announcement.
2021-03-03 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1928 characters) and contains the header 'RNS Number : 7627Q'. The content describes a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. It explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, IR, or 10-K. Since it is a general regulatory announcement that doesn't fit the specific categories (like DIRS, DIV, DLST), the most appropriate fallback category is Regulatory Filings (RNS).
2021-03-01 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1911 characters) and announces a 'Price Monitoring Extension' related to an auction call period on the London Stock Exchange. It explicitly mentions 'RNS Number' and states that the information is provided by 'RNS, the news service of the London Stock Exchange,' which is approved by the Financial Conduct Authority (FCA) as a Primary Information Provider. This structure strongly indicates a general regulatory announcement or market notice rather than a specific financial report (like 10-K, IR, or ER). Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, or CAP), the most appropriate fallback category is Regulatory Filings (RNS).
2021-03-01 English
Investor Presentation
Investor Presentation Classification · 1% confidence The document explicitly states in the first paragraph: 'Investor Presentation'. It further details that the company 'announces that it will provide a live presentation to accompany the interim results' via a digital platform. This directly matches the definition for Investor Presentation (IP). Although it is distributed via RNS (RNS Number: 5718Q), the core content being announced is the presentation itself, not a regulatory filing or a report release announcement (RPA). The document length (4213 chars) is substantial enough to be the announcement itself, but the subject matter is clearly the presentation.
2021-03-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.